NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE210465 Query DataSets for GSE210465
Status Public on May 04, 2023
Title Gain and loss of function variants in EZH1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders [ChIP-seq]
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Genetic disruption of chromatin regulators is frequently found in neurodevelopmental disorders (NDDs). While chromatin regulators are attractive therapeutic targets, studies to determine their implication in the etiology of NDDs are limited, preventing advances in diagnosis and treatment strategies. Here, we uncover pathogenic variants in the chromatin modifier Enhancer of Zeste Homologue 1 (EZH1) as the cause of overlapping dominant and recessive NDDs in 19 individuals. EZH1 encodes one of the two alternative histone H3 lysine 27 (H3K27) methyltransferases of the Polycomb Repressive Complex 2 (PRC2). Unlike the other PRC2 subunits, which are associated with the pathogenesis of human cancers and developmental disorders with overgrowth, the implication of EZH1 in human development and disease is largely unknown. Using cellular models and biochemical studies, we demonstrate that EZH1 variants identified in our study alter EZH1 molecularly. While recessive variants are EZH1 loss of function (LOF) variants that impair EZH1 expression, dominant variants are all missense mutations that affect evolutionarily conserved aminoacids likely impacting EZH1 structure or function. Accordingly, we found increased H3K27 methyltransferase activity for two EZH1 missense variants we tested, thus generating EZH1 gain of function (GOF) variants. Furthermore, we show that EZH1 is necessary and sufficient to differentiate neural stem cells in the developing chick embryo neural tube. Finally, using human pluripotent stem cell (hPSC)-derived neural cultures and forebrain organoids, we demonstrate that EZH1 LOF and GOF variation perturbs cortical projection neuron differentiation. Our work identifies EZH1 LOF and GOF variants as the genetic basis of previously undefined recessives and dominant NDDs and uncovers an essential role of EZH1 in regulating neurogenesis.
 
Overall design Chromatin immunoprecipitation DNA-sequencing (ChIP-seq) for the histone modifications H3K27me3 in ReNcells VM overexpressing EZH1 or EZH1 GOF variant (p.A678G).
 
Contributor(s) Gracia-Diaz C, Zhou Y, Zhang S, Akizu N
Citation(s) 37433783
Submission date Aug 03, 2022
Last update date Aug 03, 2023
Contact name Carolina C Gracia-Diaz
E-mail(s) ccgracia@pennmedicine.upenn.edu
Organization name The Children's Hospital of Philadelphia
Department Raymond G. Perelman Center for Cellular and Molecular Therapeutics
Lab Akizu Lab
Street address 3501 Civic Center Boulevard
City Philadelphia
State/province PA
ZIP/Postal code 19104
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (18)
GSM6430760 GFP, input, R1
GSM6430761 GFP, input, R2
GSM6430762 GFP, input, R3
This SubSeries is part of SuperSeries:
GSE227016 Gain and loss of function variants in EZH1 disrupt neurogenesis and cause overlapping neurodevelopmental disorders.
Relations
BioProject PRJNA865756

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE210465_A678G_K27_merged_CPM.bw 215.9 Mb (ftp)(http) BW
GSE210465_GFP_peaks.broadPeak.gz 817.2 Kb (ftp)(http) BROADPEAK
GSE210465_RAW.tar 2.9 Gb (http)(custom) TAR (of BW)
GSE210465_WT_K27_merged_CPM.bw 193.2 Mb (ftp)(http) BW
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap